Enveric Biosciences shares are trading higher after the company announced it signed three non-binding term sheets to pursue the out-licensing of three classes of compounds.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.